Launch of Phase 3 clinical trial with Nefecon in Japan
Go back to Launch of Phase 3 clinical trial with Nefecon in Japan| (NASDAQ: CALT) | Delayed: 40.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.00 | 52 Week High | $ | |||
| Open | $40.00 | 52 Week Low | $ | |||
| Day High | $40.00 | P/E | N/A | |||
| Day Low | $40.00 | EPS | $ | |||
| Volume | 1,511,045 | |||||
